Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Alicia Morgans, MD, MPH
CONTACT
Lead
Dana-Farber Cancer Institute
With
This research is being done to test a program to assess and manage reversible cardiovascular (CV) risk factors in participants with prostate cancer starting androgen deprivation therapy (ADT), with the goal of integrating a standardized method into Dana-Farber Cancer Institute clinics for all such participants. Study procedures including screening for eligibility, treatment visits, questionnaires and surveys, and blood and urine tests. Participation in this research study is expected to last about 6 months. It is expected that about 60-150 people will take part in this study. This study is supported by the National Comprehensive Cancer Network (NCCN) through grant funding provided by Pfizer Myovant.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted